— Know what they know.
Not Investment Advice
Also trades as: ARGX.BR (BRU) · $vol 83M · 0QW0.IL (IOB) · $vol 25M · 0QW0.L (LSE) · $vol 25M · ARGNF (OTC) · $vol 0M

ARGX NASDAQ

argenx SE
1W: -4.2% 1M: -12.9% 3M: +0.3% YTD: +9.4% 1Y: +19.8% 3Y: +92.4% 5Y: +198.4%
$919.21
-16.79 (-1.79%)
 
Weekly Expected Move ±2.9%
$865 $892 $919 $946 $973
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 39 · $57.2B mcap · 62M float · 0.494% daily turnover · Short 53% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
59.6 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 76.3%  ·  5Y Avg: 40.5%
Cost Advantage
59
Intangibles
44
Switching Cost
62
Network Effect
80
Scale
62
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ARGX has a Narrow competitive edge (59.6/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 76.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$932
Low
$1155
Avg Target
$1415
High
Based on 19 analysts since Jul 23, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 31Hold: 4Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$1144.80
Analysts20
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-31 Morgan Stanley — $1230 $1250 +20 +22.2% $1023.21
2026-08-26 Wells Fargo Derek Archila $1350 $1415 +65 +38.8% $1019.49
2026-08-26 UBS Xian Deng $910 $1400 +490 +37.3% $1019.49
2026-08-18 Morgan Stanley — $1200 $1230 +30 +24.3% $989.79
2026-08-18 Wedbush — $1050 $1150 +100 +16.4% $987.84
2026-08-18 Oppenheimer — $1037 $1100 +63 +11.4% $987.84
2026-08-18 RBC Capital Luca Issi $1025 $1100 +75 +11.4% $987.84
2026-08-18 Truist Financial Danielle Brill $1030 $1095 +65 +10.8% $987.84
2026-08-18 H.C. Wainwright — $940 $1202 +262 +21.7% $987.84
2026-08-17 Piper Sandler — $930 $1215 +285 +42.7% $851.29
2026-07-28 Wedbush — $880 $1050 +170 +19.5% $878.42
2026-07-27 Robert W. Baird — $858 $932 +74 +1.5% $918.22
2026-07-24 Barclays — Initiated $950 — +3.4% $918.80
2026-07-24 Morgan Stanley — $1180 $1200 +20 +30.9% $916.69
2026-07-24 Oppenheimer — $546 $1037 +491 +12.3% $923.26
2026-07-24 Leerink Partners — Initiated $1065 — +15.2% $924.60
2026-07-24 Guggenheim — $1135 $1185 +50 +28.2% $924.60
2026-07-24 Wells Fargo — $1291 $1350 +59 +46.0% $924.60
2026-07-23 RBC Capital — $945 $1025 +80 +10.9% $924.60
2026-07-07 RBC Capital — $890 $945 +55 +3.1% $916.80
2026-06-24 RBC Capital Luca Issi $925 $890 -35 +4.0% $855.84
2026-06-24 Morgan Stanley Sean Laaman $1170 $1180 +10 +35.7% $869.41
2026-06-04 H.C. Wainwright Douglas Tsao $915 $940 +25 +15.6% $813.14
2026-06-01 Wells Fargo — $1260 $1291 +31 +54.4% $835.99
2026-05-28 Stifel Nicolaus Alex Thompson $1222 $1255 +33 +49.7% $838.49
2026-05-08 Morgan Stanley Sean Laaman $1160 $1170 +10 +48.3% $788.73
2026-05-08 Guggenheim Yatin Suneja $1160 $1135 -25 +44.2% $787.31
2026-05-08 Wells Fargo — $1317 $1260 -57 +60.0% $787.31
2026-05-07 Stifel Nicolaus — $1227 $1222 -5 +55.7% $784.96
2026-02-26 Stifel Nicolaus Alex Thompson $1248 $1227 -21 +59.4% $769.98
2026-01-20 Wells Fargo — $542 $1317 +775 +64.6% $800.01
2026-01-08 Truist Financial Danielle Brill $540 $1030 +490 +25.2% $822.94
2026-01-08 Morgan Stanley Sean Laaman $1110 $1160 +50 +41.0% $822.94
2025-12-18 Guggenheim Yatin Suneja $330 $1160 +830 +36.4% $850.57
2025-12-18 Needham — Initiated $1006 — +16.7% $862.05
2025-12-18 Robert W. Baird Collen Kusy $924 $858 -66 -0.5% $862.05
2025-12-17 RBC Capital — $850 $925 +75 +7.1% $863.37
2025-12-11 Stifel Nicolaus — $882 $1248 +366 +40.3% $889.76
2025-12-09 UBS Xian Deng $390 $910 +520 +1.0% $900.76
2025-12-04 Morgan Stanley Sean Laaman $1040 $1110 +70 +20.6% $920.45
2025-11-04 Piper Sandler — $820 $930 +110 +10.4% $842.67
2025-10-31 Evercore ISI — $533 $910 +377 +11.9% $812.88
2025-10-31 Cowen & Co. — Initiated $1146 — +40.3% $816.82
2025-10-31 Robert W. Baird — $680 $924 +244 +11.5% $828.85
2025-10-31 H.C. Wainwright — $533 $915 +382 +11.5% $820.36
2025-10-13 Wedbush — $382 $880 +498 +10.4% $796.92
2025-10-01 Morgan Stanley — Initiated $1040 — +41.0% $737.56
2025-09-18 Stifel Nicolaus Alex Thompson $500 $882 +382 +20.5% $731.77
2025-08-26 Piper Sandler — Initiated $820 — +17.3% $698.99
2025-08-26 Jefferies — $362 $818 +456 +17.0% $698.99

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
3
ROE
5
ROA
5
D/E
2
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ARGX receives an overall rating of B+. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-10 A- B+
2026-07-01 B+ A-
2026-06-22 A- B+
2026-05-26 B+ A-
2026-05-20 A- B+
2026-05-11 B+ A-
2026-04-30 A- B+
2026-04-24 B+ A-
2026-04-01 A- B+
2026-01-26 A A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 74 Grade A
Profitability
98
Balance Sheet
96
Earnings Quality
20
Growth
81
Value
49
Momentum
78
Safety
100
Cash Flow
64
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ARGX scores highest in Safety (100/100) and lowest in Earnings Quality (20/100). An overall grade of A places ARGX among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
24.58
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✓ ✗ ✓ ✗ ✗ ✗ ✓
Beneish M-Score
0.90
Possible Manipulator
Ohlson O-Score
-13.72
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 97.1/100
Trend: Improving
Earnings Quality
50/100
OCF/NI: 0.55x
Accruals: 18.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ARGX scores 24.58, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ARGX scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ARGX's score of 0.90 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ARGX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ARGX receives an estimated rating of AAA (score: 97.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ARGX's score of 50/100 is moderate — some divergence between reported earnings and underlying cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
33.26x
PEG
0.10x
P/S
11.00x
P/B
6.78x
P/FCF
36.68x
P/OCF
36.45x
EV/EBITDA
25.08x
EV/Revenue
6.57x
EV/EBIT
25.72x
EV/FCF
33.53x
Earnings Yield
5.01%
FCF Yield
2.73%
Shareholder Yield
0.04%
Graham Number
$369.85
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 33.3x earnings, ARGX commands a growth premium. An earnings yield of 5.0% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $369.85 per share, 149% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.242
NI / EBT
×
Interest Burden
1.136
EBT / EBIT
×
EBIT Margin
0.255
EBIT / Rev
×
Asset Turnover
1.122
Rev / Assets
×
Equity Multiplier
1.170
Assets / Equity
=
ROE
47.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ARGX's ROE of 47.3% is driven by Asset Turnover (1.122), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.24 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$395.43
Price/Value
2.35x
Margin of Safety
-134.62%
Premium
134.62%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ARGX's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ARGX trades at a 135% premium to its adjusted intrinsic value of $395.43, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 33.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$919.21
Median 1Y
$1104.46
5th Pctile
$541.20
95th Pctile
$2265.96
Ann. Volatility
41.5%
Analyst Target
$1144.80
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,863
+16.5% YoY
Revenue / Employee
$2,235,191
Rev: $4,164,161,014
Profit / Employee
$695,670
NI: $1,296,032,818
SGA / Employee
$736,064
Avg labor cost proxy
R&D / Employee
$734,489
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
ROE -4.8% -6.8% -12.5% -15.4% -28.4% -28.8% -37.3% -59.1% -31.2% -47.1% -45.5% -46.0% -41.3% -28.4% -15.4% 13.6% 20.6% 37.2% 47.3% 47.27%
ROA -4.4% -6.3% -11.6% -14.3% -19.8% -22.3% -30.6% -46.1% -26.5% -39.2% -39.5% -38.1% -37.4% -25.4% -13.8% 12.1% 17.8% 32.1% 40.4% 40.41%
ROIC 3.4% 1.2% 6.0% 2.9% 39.3% 65.7% 98.2% 1.5% -1.6% -2.7% -1.9% -1.2% -1.1% -91.7% -56.1% -15.7% -7.1% 54.0% 76.3% 76.29%
ROCE -4.7% -5.5% -12.6% -16.7% -14.6% -18.1% -21.1% -30.2% -15.4% -28.7% -31.2% -36.2% -44.8% -25.0% -15.4% -4.4% 7.3% 16.9% 25.1% 25.11%
Gross Margin -7.0% -53.4% -67.7% -4.6% -52.6% -2.8% -4.5% -5.6% 45.1% -9.3% -1.5% -25.6% 22.9% 24.3% 1.4% 50.6% 88.3% 89.4% 90.1% 90.08%
Operating Margin -27.5% -1.2% -1.2% -6.5% -1.1% -4.0% -6.5% -9.2% 19.1% -15.0% -3.4% -99.6% -40.3% -28.9% -15.4% 8.7% 21.2% 26.5% 30.1% 30.07%
Net Margin -33.4% -1.2% -97.9% -5.3% -88.0% -3.8% -6.6% -13.8% 12.7% -15.9% -3.7% -84.4% -24.1% -20.5% -3.6% 64.3% 25.9% 32.7% 29.8% 29.79%
EBITDA Margin -26.6% -97.2% -1.2% -6.4% -1.0% -4.0% -6.4% -9.2% 19.7% -15.2% -3.4% -70.6% -39.0% -5.0% -2.4% 9.4% 54.2% 21.0% 30.7% 30.68%
FCF Margin -63.7% -90.0% -1.1% -1.3% 1.6% 70.2% -22.7% -1.5% -1.2% -1.7% -2.1% -1.6% -1.6% -74.0% -35.7% -13.9% 5.4% 11.8% 19.6% 19.59%
OCF Margin -68.2% -1.0% -1.2% -1.5% 1.8% 85.1% -14.4% -1.8% -1.4% -2.0% -2.3% -1.7% -1.6% -76.1% -36.1% -13.7% 5.6% 11.9% 19.7% 19.71%
ROE 3Y Avg snapshot only -4.72%
ROE 5Y Avg snapshot only -9.85%
ROA 3Y Avg snapshot only -5.09%
ROIC Economic snapshot only 30.16%
Cash ROA snapshot only 16.34%
Cash ROIC snapshot only 49.98%
CROIC snapshot only 49.67%
NOPAT Margin snapshot only 30.09%
Pretax Margin snapshot only 29.01%
R&D / Revenue snapshot only 18.69%
SGA / Revenue snapshot only 27.57%
SBC / Revenue snapshot only 1.54%
Valuation
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
P/E Ratio -56.31 -61.76 -55.71 -34.96 -40.61 -27.60 -23.82 -20.56 -28.08 -20.61 -18.59 -20.29 -18.11 -23.58 -45.89 77.31 39.22 26.20 19.94 33.262
P/S Ratio 18.78 42.30 43.63 47.15 55.15 56.67 80.37 102.57 32.19 36.10 34.89 24.34 23.89 13.52 10.51 12.56 9.15 8.70 7.19 11.004
P/B Ratio 2.68 4.19 6.97 5.38 7.07 5.37 5.39 8.32 5.51 7.12 6.82 7.45 7.59 5.41 5.99 7.94 5.94 7.60 7.10 6.780
P/FCF -29.49 -47.00 -41.42 -36.24 35.19 80.70 -354.54 -67.98 -26.04 -20.83 -16.82 -15.58 -15.34 -18.26 -29.45 -90.57 170.04 73.74 36.68 36.680
P/OCF — — — — 30.83 66.61 — — — — — — — — — — 164.34 72.97 36.45 36.453
EV/EBITDA -44.02 -57.87 -48.05 -25.66 -28.35 -18.60 -17.65 -20.42 -30.18 -21.83 -19.64 -20.76 -16.86 -23.44 -49.27 -348.40 55.61 39.70 25.08 25.081
EV/Revenue 11.72 31.77 37.25 37.95 44.12 43.31 62.59 87.93 26.80 31.45 30.43 21.81 21.70 11.59 9.25 11.60 8.17 8.02 6.57 6.568
EV/EBIT -42.65 -56.79 -47.41 -25.90 -28.40 -18.65 -17.63 -20.27 -29.55 -21.45 -18.96 -18.31 -15.30 -18.44 -33.87 -167.29 72.33 41.16 25.72 25.719
EV/FCF -18.40 -35.30 -35.37 -29.17 28.15 61.68 -276.12 -58.28 -21.68 -18.14 -14.67 -13.96 -13.93 -15.66 -25.92 -83.64 151.78 67.97 33.53 33.527
Earnings Yield -1.8% -1.6% -1.8% -2.9% -2.5% -3.6% -4.2% -4.9% -3.6% -4.9% -5.4% -4.9% -5.5% -4.2% -2.2% 1.3% 2.5% 3.8% 5.0% 5.01%
FCF Yield -3.4% -2.1% -2.4% -2.8% 2.8% 1.2% -0.3% -1.5% -3.8% -4.8% -5.9% -6.4% -6.5% -5.5% -3.4% -1.1% 0.6% 1.4% 2.7% 2.73%
PEG Ratio snapshot only 0.097
Price/Tangible Book snapshot only 7.331
EV/OCF snapshot only 33.319
EV/Gross Profit snapshot only 7.892
Acquirers Multiple snapshot only 27.095
Shareholder Yield snapshot only 0.04%
Graham Number snapshot only $369.85
Leverage & Solvency
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Current Ratio 5.16 14.96 13.16 14.29 9.37 8.58 9.90 6.26 11.74 8.44 11.07 9.18 8.47 9.75 8.53 7.29 5.60 5.23 5.12 5.123
Quick Ratio 5.16 14.96 13.16 14.29 9.37 8.58 9.87 6.19 11.50 8.08 10.56 8.42 7.84 9.01 7.88 6.68 5.27 4.87 4.89 4.887
Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.006
Net Debt/Equity -1.01 -1.04 -1.02 -1.05 -1.41 -1.27 -1.19 -1.19 -0.92 -0.92 -0.87 -0.77 -0.69 -0.77 -0.72 -0.61 -0.64 -0.59 -0.61 -0.610
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.005
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.02 -0.07 -0.34 0.07 0.06 0.02 0.022
Net Debt/EBITDA 26.51 19.18 8.22 6.22 7.09 5.73 5.01 3.40 6.07 3.23 2.88 2.41 1.70 3.90 6.73 28.87 -6.69 -3.37 -2.36 -2.359
Interest Coverage — — — — — — -180.32 -245.49 -145.70 -233.08 -324.94 -220.80 -300.01 -225.35 -219.48 -123.55 166.64 366.49 439.51 439.512
Equity Multiplier 1.08 1.08 1.08 1.07 1.52 1.36 1.25 1.36 1.09 1.12 1.09 1.11 1.12 1.11 1.13 1.13 1.18 1.19 1.19 1.192
Cash Ratio snapshot only 3.291
Debt Service Coverage snapshot only 450.702
Cash to Debt snapshot only 110.298
FCF to Debt snapshot only 34.663
Defensive Interval snapshot only 530.4 days
Efficiency & Turnover
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Asset Turnover 0.13 0.09 0.15 0.11 0.15 0.11 0.09 0.09 0.23 0.22 0.21 0.32 0.28 0.44 0.60 0.74 0.76 0.97 1.12 1.122
Inventory Turnover — — — — — — 148.41 40.86 22.54 14.99 13.15 9.16 9.92 7.60 4.05 3.84 3.58 1.88 4.00 4.000
Receivables Turnover 5.04 40.43 5.97 240.08 38.52 7.51 12.23 468.50 82.73 17.58 9.51 7.13 5.74 7.35 7.74 6.56 5.53 6.20 7.08 7.083
Payables Turnover 1.76 9.75 3.41 19.67 4.82 35.64 4.92 4.83 4.42 7.45 5.98 5.88 5.94 7.02 4.18 4.60 2.67 0.97 2.79 2.793
DSO 72 9 61 2 9 49 30 1 4 21 38 51 64 50 47 56 66 59 52 51.5 days
DIO 0 0 0 0 0 0 2 9 16 24 28 40 37 48 90 95 102 194 91 91.3 days
DPO 207 37 107 19 76 10 74 76 83 49 61 62 61 52 87 79 137 375 131 130.7 days
Cash Conversion Cycle -135 -28 -46 -17 -66 38 -42 -66 -62 -4 5 29 39 46 50 71 31 -122 12 12.1 days
Fixed Asset Turnover snapshot only 159.914
Operating Cycle snapshot only 142.8 days
Cash Velocity snapshot only 1.604
Capital Intensity snapshot only 1.206
Growth (YoY)
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue — — — — 2.9% 1.7% 98.1% 93.3% 4.2% 3.5% 3.8% 5.3% 79.9% 2.3% 3.2% 3.0% 3.4% 2.9% 2.4% 2.42%
Net Income — — — — -15.1% -7.2% -7.5% -6.1% -3.4% -2.8% -1.7% -52.5% -1.1% -7.4% 48.9% 1.5% 1.8% 3.3% 6.4% 6.38%
EPS — — — — -8.3% -4.7% -5.4% -4.2% -2.1% -1.9% -1.2% -30.5% -1.0% 5.0% 54.0% 1.4% 1.7% 3.0% 6.0% 5.96%
FCF — — — — 10.7% 3.1% 57.4% -1.2% -5.1% -12.0% -42.6% -5.6% -1.3% -40.2% 28.0% 64.2% 1.2% 1.6% 2.9% 2.88%
EBITDA — — — — -22.1% -10.6% -8.1% -4.6% -2.0% -1.8% -1.1% -54.7% -1.6% -12.7% 49.3% 87.2% 1.5% 2.6% 5.8% 5.77%
Op. Income — — — — -22.1% -9.0% -7.4% -4.4% -1.9% -1.8% -1.1% -69.2% -1.8% -51.9% 5.5% 56.6% 96.8% 1.9% 3.4% 3.38%
OCF Growth snapshot only 2.87%
Asset Growth snapshot only 1.09%
Equity Growth snapshot only 97.48%
Debt Growth snapshot only 38.40%
Shares Change snapshot only 8.43%
Growth (CAGR)
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — 2.3% 2.4% 2.4% 2.7% 2.4% 2.9% 3.1% 3.09%
Revenue 5Y — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — 11.9% 1.1% — —
FCF 5Y — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — 8.3% 1.0% — —
OCF 5Y — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 1.6% 1.2% 1.3% 1.1% 84.2% 75.4% 64.0% 63.99%
Assets 5Y — — — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — 1.6% 1.1% 1.2% 1.1% 1.0% 83.7% 66.7% 66.67%
Book Value 3Y — — — — — — — — — — — — 86.6% 67.1% 82.1% 63.1% 66.7% 54.7% 46.2% 46.20%
Dividend 3Y — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue Stability — — — — — — — — 0.86 0.86 0.84 0.81 0.93 0.82 0.77 0.78 0.77 0.79 0.82 0.819
Earnings Stability — — — — — — — — 0.90 0.92 0.97 0.98 0.93 0.91 0.43 0.09 0.03 0.21 0.34 0.337
Margin Stability — — — — — — — — 0.00 0.19 0.02 0.06 0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.50 0.50 0.50 0.50 0.50 0.97 0.80 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -0.09 -0.21 -0.19 -0.09 -0.23 0.04 0.17 0.49 0.46 0.58 0.60 0.605
Gross Margin Trend — — — — — — — — 0.18 0.25 0.80 1.51 0.20 1.10 2.12 2.22 1.13 1.19 0.82 0.825
FCF Margin Trend — — — — — — — — -1.70 -1.63 -1.43 -0.16 -1.72 -0.22 0.79 1.40 1.45 1.35 1.41 1.412
Sustainable Growth Rate — — — — — — — — — — — — — — — 13.6% 20.6% 37.2% 47.3% 47.27%
Internal Growth Rate — — — — — — — — — — — — — — — 13.8% 21.7% 47.4% 67.8% 67.83%
Cash Flow Quality
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
OCF/Net Income 2.05 1.52 1.54 1.09 -1.32 -0.41 0.04 0.35 1.25 1.14 1.24 1.41 1.25 1.33 1.58 -0.84 0.24 0.36 0.55 0.547
FCF/OCF 0.93 0.87 0.87 0.89 0.88 0.83 1.57 0.86 0.86 0.87 0.89 0.92 0.95 0.97 0.99 1.01 0.97 0.99 0.99 0.994
FCF/Net Income snapshot only 0.544
OCF/EBITDA snapshot only 0.753
CapEx/Revenue 1.3% 0.8% 1.0% 1.4% 1.5% 2.1% 2.2% 1.9% 0.8% 0.8% 0.6% 0.5% 0.3% 0.1% 0.1% 0.1% 0.2% 0.1% 0.1% 0.12%
CapEx/Depreciation snapshot only 0.188
Accruals Ratio 0.05 0.03 0.06 0.01 -0.46 -0.32 -0.29 -0.30 0.07 0.06 0.09 0.16 0.09 0.08 0.08 0.22 0.14 0.21 0.18 0.183
Sloan Accruals snapshot only 0.361
Cash Flow Adequacy snapshot only 161.637
Earnings Quality Score snapshot only 0.500
Dividends & Buybacks
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio — — — — 0.0% 0.0% — — — — — — — — — — 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — — — 6.0% 4.1% 1.2% 0.8% 0.82%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.04%
Net Buyback Yield -22.1% -20.7% -13.5% -19.3% -13.9% -16.0% -18.6% -11.3% -15.2% -10.9% -9.7% -9.2% -3.8% -3.6% 0.1% 0.1% 0.1% -0.3% -0.5% -0.49%
Total Shareholder Return -22.1% -20.7% -13.5% -19.3% -13.9% -16.0% -18.6% -11.3% -15.2% -10.9% -9.7% -9.2% -3.8% -3.6% 0.1% 0.1% 0.1% -0.3% -0.5% -0.49%
DuPont Factors
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Tax Burden (NI/EBT) 0.94 0.98 0.93 0.91 0.94 0.98 0.95 0.89 0.88 0.86 0.89 0.94 0.91 0.96 0.86 -2.74 4.05 1.56 1.24 1.242
Interest Burden (EBT/EBIT) 1.29 1.25 1.08 1.01 0.93 0.90 1.00 1.30 1.43 1.39 1.31 1.07 1.02 0.95 0.97 0.85 0.51 1.09 1.14 1.136
EBIT Margin -0.27 -0.56 -0.79 -1.47 -1.55 -2.32 -3.55 -4.34 -0.91 -1.47 -1.60 -1.19 -1.42 -0.63 -0.27 -0.07 0.11 0.19 0.26 0.255
Asset Turnover 0.13 0.09 0.15 0.11 0.15 0.11 0.09 0.09 0.23 0.22 0.21 0.32 0.28 0.44 0.60 0.74 0.76 0.97 1.12 1.122
Equity Multiplier 1.08 1.08 1.08 1.07 1.44 1.29 1.22 1.28 1.18 1.20 1.15 1.21 1.10 1.11 1.11 1.12 1.16 1.16 1.17 1.170
Per Share
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
EPS (Diluted TTM) $-0.38 $-1.02 $-1.49 $-2.75 $-3.49 $-5.82 $-9.46 $-14.30 $-10.72 $-16.99 $-20.39 $-18.67 $-21.53 $-16.13 $-9.37 $7.96 $14.06 $32.10 $46.52 $46.52
Book Value/Share $7.90 $15.07 $11.89 $17.87 $20.03 $29.90 $41.82 $35.36 $54.68 $49.20 $55.57 $50.87 $51.32 $70.31 $71.75 $77.49 $92.85 $110.63 $130.68 $135.35
Tangible Book/Share $7.90 $15.07 $11.89 $17.87 $18.97 $28.76 $40.76 $31.82 $51.43 $45.86 $52.37 $47.71 $47.91 $68.16 $69.37 $74.93 $89.51 $106.52 $126.55 $126.55
Revenue/Share $1.13 $1.49 $1.90 $2.04 $2.57 $2.83 $2.80 $2.87 $9.35 $9.70 $10.86 $15.56 $16.31 $28.14 $40.92 $48.96 $60.22 $96.71 $129.10 $83.40
FCF/Share $-0.72 $-1.34 $-2.00 $-2.65 $4.02 $1.99 $-0.64 $-4.33 $-11.56 $-16.81 $-22.53 $-24.32 $-25.41 $-20.83 $-14.60 $-6.79 $3.24 $11.40 $25.29 $18.00
OCF/Share $-0.77 $-1.55 $-2.30 $-2.99 $4.59 $2.41 $-0.40 $-5.02 $-13.38 $-19.37 $-25.22 $-26.39 $-26.81 $-21.42 $-14.79 $-6.71 $3.35 $11.52 $25.45 $18.05
Cash/Share $7.97 $15.72 $12.10 $18.74 $28.43 $38.02 $50.00 $42.17 $50.58 $45.36 $48.59 $39.64 $35.86 $54.56 $52.23 $47.62 $59.83 $67.07 $80.49 $83.36
EBITDA/Share $-0.30 $-0.82 $-1.47 $-3.01 $-4.00 $-6.60 $-9.94 $-12.35 $-8.31 $-13.97 $-16.82 $-16.35 $-21.00 $-13.91 $-7.68 $-1.63 $8.85 $19.52 $33.81 $33.81
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.11 $0.19 $0.18 $0.20 $0.15 $0.22 $0.18 $0.22 $0.20 $0.34 $0.57 $0.55 $0.66 $1.26 $0.73 $0.73
Net Debt/Share $-7.97 $-15.72 $-12.10 $-18.74 $-28.32 $-37.83 $-49.82 $-41.96 $-50.44 $-45.14 $-48.41 $-39.41 $-35.66 $-54.22 $-51.66 $-47.07 $-59.18 $-65.81 $-79.76 $-79.76
Academic Models
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — 24.583
Altman Z-Prime snapshot only 44.701
Piotroski F-Score 1 1 1 1 4 3 1 1 4 2 4 4 1 4 3 4 5 5 5 5
Beneish M-Score — — — — -4.05 17.85 -3.13 1.45 3.15 -2.37 4.31 22.08 21.91 1.77 3.08 0.93 -0.64 1.37 0.90 0.900
Ohlson O-Score snapshot only -13.719
ROIC (Greenblatt) snapshot only 32.45%
Net-Net WC snapshot only $100.19
EVA snapshot only $2174269575.96
Credit
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Credit Rating snapshot only AAA
Credit Score 89.00 89.00 89.00 89.00 82.59 82.34 62.53 61.34 59.60 61.07 63.94 65.57 65.15 65.69 65.41 65.28 96.97 96.87 97.10 97.098
Credit Grade snapshot only 1
Credit Trend snapshot only 31.691
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 96
Sector Credit Rank snapshot only 93

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms